This invention is directed to pyridopyrimidinone compounds of formula (I):
wherein n, R
1
, R
2
and R
3
are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
本发明涉及式(I)的
吡啶吡嘧啶酮化合物:其中n,R1,R2和R3如本文所定义,作为立体异构体,对映异构体,互变异构体或其混合物;或其药用可接受盐,溶剂合物或前药,用于治疗和/或预防
钠通道介导的疾病或症状,如疼痛。